Young-adulthood insulin resistance (IR) was linked to a 1.50-fold higher risk of atherosclerotic cardiovascular disease (ASCVD) later in life. Midlife metabolic syndrome (MetS) mediated 63.4% of this association. The analysis included 3,622 Black and White participants in the US CARDIA study. They were aged 18–30 at baseline and free of ASCVD through year 20. IR was defined as a Homeostatic Model Assessment of Insulin Resistance value ≥2.67 (75th percentile). MetS was assessed at year 20, and ASCVD events were ascertained through year 35. Parametric g-computation with pooled logistic regression estimated total and mediated effects on cumulative ASCVD risk. Midlife lifestyle factors were treated as exposure-induced mediator-outcome confounders. At baseline, 907 participants (25%) had IR. During a median follow-up of 14 years after year 20, 143 participants (3.9%) had an ASCVD event. The indirect risk ratio through midlife MetS was 1.29. These findings suggest that early identification of IR and prevention of progression to MetS may help reduce long-term cardiovascular risk. Source: https://www.jacc.org/
A long-term French study of 1,540 older adults found that only chronic loneliness significantly increases…
In a randomized, sham-controlled trial of 132 Chinese women aged 18 to 45 years with…
In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with…
A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins…
People with type 2 diabetes (T2D) develop Alzheimer's disease (AD) at a rate of about…
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
This website uses cookies.